Marcin Fijalkowski
Overview
Explore the profile of Marcin Fijalkowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
100
Citations
1388
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kwiatkowska M, Mickiewicz A, Krzesinska A, Kuchta A, Jankowski M, Gruchala M, et al.
Antioxidants (Basel)
. 2025 Feb;
14(2).
PMID: 40002354
The bicuspid aortic valve (BAV) is commonly associated with the early degeneration of the aortic valve. Up to 45% of BAV patients over the age of 50 develop aortic stenosis...
2.
Kaufmann D, Nowak R, Meyer-Szary J, Dorniak K, Swiatczak M, Fijalkowski M, et al.
Kardiol Pol
. 2025 Jan;
82(12):1293-1294.
PMID: 39775561
No abstract available.
3.
Krzesinska A, Marlega-Linert J, Chyla-Danil G, Marcinkowska M, Rogowska P, Stumska K, et al.
Int J Mol Sci
. 2025 Jan;
25(24.
PMID: 39769362
Oxidative modifications of lipoproteins play a crucial role in the initiation of atherosclerotic cardiovascular diseases (ASCVDs). Nowadays, the one effective strategy for the treatment of patients with hyperlipoproteinemia(a) is lipoprotein...
4.
Gasecka A, Jasinska-Gniadzik K, DAscenzo F, Angelini F, Lomiak M, Pregowski J, et al.
Am J Cardiol
. 2024 Nov;
238:12-20.
PMID: 39613282
The Cardiovascular Outcomes Assessment for Heart Failure Patients with Functional Mitral Regurgitation (COAPT) risk score predicts the risk of death or hospitalization for heart failure within 2 years after transcatheter...
5.
Mizia-Stec K, Tycinska A, Cieplucha A, Kaplon-Cieslicka A, Torbicki A, Leszek P, et al.
Kardiol Pol
. 2024 Sep;
82(9):895-898.
PMID: 39240925
No abstract available.
6.
Kaufmann D, Krolak T, Dabrowska-Kugacka A, Kaplon-Cieslicka A, Gawalko M, Budnik M, et al.
Kardiol Pol
. 2024 Apr;
82(5):492-499.
PMID: 38606739
Background: According to the present guidelines, transesophageal echocardiography (TEE) before scheduled catheter ablation (CA) for atrial arrhythmias (atrial fibrillation [AF] or atrial flutter [AFL]) is not deemed obligatory for optimally...
7.
Marlega-Linert J, Gasecka A, van der Pol E, Kuchta A, Filipiak K, Fijalkowski M, et al.
Sci Rep
. 2024 Feb;
14(1):2762.
PMID: 38307884
Lipoprotein apheresis (LA) is a therapeutic option for hyperlipoproteinemia(a) (hyper-Lp(a)) and atherosclerotic cardiovascular disease (ASCVD). LA improves blood rheology, reduces oxidative stress parameters and improves endothelial function. The underlying molecular...
8.
Mickiewicz A, Marlega-Linert J, Czapiewska M, Marcinkowska M, Krzesinska A, Kuchta A, et al.
J Clin Lipidol
. 2023 Dec;
18(2):e197-e206.
PMID: 38092592
Background: Lipoprotein apheresis (LA) is an extracorporeal treatment that transiently reduces lipoprotein (a) [Lp(a)] by 60% and leads to an 80-92% reduction in major adverse cardiovascular events. LA has a...
9.
Marlga-Linert J, Wartecka-Zielinska K, Wydra D, Fijalkowski M, Gruchala M, Mickiewicz A
Front Med (Lausanne)
. 2023 Oct;
10:1190446.
PMID: 37799590
Background: Preeclampsia is a common and serious pregnancy-induced disease, with potential severe maternal and fetal complications. Recently, an increased lipoprotein (a) (Lp[a]) concentration, an important factor in cardiovascular diseases (CVDs)...
10.
Galaska R, Kulawiak-Galaska D, Dorniak K, Strozyk A, Sabisz A, Chmara M, et al.
J Clin Med
. 2023 Sep;
12(17).
PMID: 37685656
We aimed to compare the extent of subclinical atherosclerosis in the ascending and descending aortas by measuring wall area and thickness using 3D cardiovascular magnetic resonance imaging (aAWAI and dAWAI)...